A prospective study on neoadjuvant chemoradiotherapy plus anti-EGFR monoclonal antibody followed by surgery for locally advanced cervical cancer

References

• VizcainoAPMorenoVBoschFXInternational trends in incidence of cervical cancer. II: Squamous-cell carcinomaInt J Cancer200086342943510760834
   PubMed Web of Science ®Google Scholar
• MonkBJTewariKSKohWJMultimodality therapy for locally advanced cervical carcinoma: state of the art and future directionsJ Clin Oncol200725202952296517617527
   PubMed Web of Science ®Google Scholar
• ThomasGMImproved treatment for cervical cancer-concurrent chemotherapy and radiotherapyN Engl J Med1999340151198120010202172
   PubMed Web of Science ®Google Scholar
• GreenJAKirwanJMTierneyJFSurvival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysisLancet2001358928478178611564482
   PubMed Web of Science ®Google Scholar
• Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer Meta-analysis CollaborationNeoadjuvant chemotherapy for locally advanced cervical cancer: a systematic review and meta-analysis of individual patient data from 21 randomised trialsEur J Cancer200339172470248614602133
   PubMed Web of Science ®Google Scholar
• ChenHLiangCZhangLHuangSWuXClinical efficacy of modified preoperative neoadjuvant chemotherapy in the treatment of locally advanced (stage IB2 to IIB) cervical cancer: randomized studyGynecol Oncol2008110330831518606439
   PubMed Web of Science ®Google Scholar
• Duenas-GonzalezALopez-GranielCGonzalez-EncisoAConcomitant chemoradiation versus neoadjuvant chemotherapy in locally advanced cervical carcinoma: results from two consecutive phase II studiesAnn Oncol20021381212121912181244
   PubMed Web of Science ®Google Scholar
• ModarressMMaghamiFQGolnavazMBehtashNMousaviAKhaliliGRComparative study of chemoradiation and neoadjuvant chemotherapy effects before radical hysterectomy in stage IB-IIB bulky cervical cancer and with tumor diameter greater than 4 cmInt J Gynecol Cancer200515348348815882173
   PubMed Web of Science ®Google Scholar
• FerrandinaGGambacortaAGallottaVChemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 studyInt J Radiat Oncol Biol Phys201490477878425585781
   PubMed Web of Science ®Google Scholar
• FerrandinaGErcoliAFagottiACompletion surgery after concomitant chemoradiation in locally advanced cervical cancer: a comprehensive analysis of pattern of postoperative complicationsAnn Surg Oncol20142151692169924407316
   PubMed Web of Science ®Google Scholar
• WykoskyJFentonTFurnariFCaveneeWKTherapeutic targeting of epidermal growth factor receptor in human cancer: successes and limitationsChin J Cancer201130151221192840
   PubMedGoogle Scholar
• SoonthornthumTArias-PulidoHJosteNEpidermal growth factor receptor as biomarker for cervical cancerAnn Oncol201122102166217821325449
   PubMed Web of Science ®Google Scholar
• CetinaLCrombetTJiménez-LimaRA pilot study of nimotuzumab plus single agent chemotherapy as second- or third-line treatment or more in patients with recurrent, persistent or metastatic cervical cancerCancer Bio Ther201516568468925802932
   PubMed Web of Science ®Google Scholar
• BasavarajCSierraPShivuJMelarkodeRMonteroENairPNimotuzumab with chemoradiation confers a survival advantage in treatment-naïve head and neck tumors overpexpressing EGFRCancer Biol Ther201010767368120647773
   PubMed Web of Science ®Google Scholar
• McNeilCNew standard of care for cervical cancer sets stage for next questionsJ Natl Cancer Inst199991650050110088618
   PubMedGoogle Scholar
• Chemoradiotherapy for Cervical Cancer Meta-analysis Collaboration (CCCMAC)Reducing uncertainties about the effect of chemoradiotherapy for cervical cancer: individual patients data meta-analysisCochrane Database Syst Rev20101CD008285
   Google Scholar
• FerrandinaGLeggeFFagottiAPreoperative concomitant chemoradiotherapy in locally advanced cervical cancer: safety, outcome, and prognostic measuresGynecol Oncol20071071 Suppl 1S127S13217727936
   PubMed Web of Science ®Google Scholar
• KoensgenDSehouliJBelauAClinical outcome of neoadjuvant radiochemotherapy in locally advanced cervical cancerInt J Gynecol Cancer201727350050628187089
   PubMed Web of Science ®Google Scholar
• GongLZhangJWYinRTSafety and efficacy of neoadjuvant chemotherapy followed by radical surgery versus radical surgery alone in locally advanced cervical cancer patientsInt J Gynecol Cancer201626472272826905330
   PubMed Web of Science ®Google Scholar
• LeeKCMoffatBASchottAFProspective early response imaging biomarker for neoadjuvant breast cancer chemotherapyClin Cancer Res2007132 Pt 144345017255264
   PubMed Web of Science ®Google Scholar
• PicklesMDGibbsPLowryMTurnbullLWDiffusion changes precede size reduction in neoadjuvant treatment of breast cancerMagn Reson Imaging200624784384716916701
   PubMed Web of Science ®Google Scholar
• FerrandinaGMargaritiPASmaniottoDLong-term analysis of clinical outcome and complication in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgeryGyneco Oncol20101193404410
   PubMed Web of Science ®Google Scholar
• MacchiaGCillaSDeodatoFIntensity-modulated extended-field chemoradiation plus simultaneous integrated boost in the pre-operative treatment of locally advanced cervical cancer: a dose-escalation studyBr J Radiol20158810552015038526388108
   PubMed Web of Science ®Google Scholar
• KatoTNishimuraHYakushijiMPhase II study of 254-S (cis-diammine glycolato platinum) for gynecological cancerGan to Kagaku Ryoho1992195695701 Japanese1580643
   PubMedGoogle Scholar
• HartmannJTLippHPToxicity of platinum compoundsExpert Opin Pharmacother20034688990112783586
   PubMed Web of Science ®Google Scholar
• FujiwaraMIsohashiFMabuchiSEfficacy and safety of nedaplatin-based concurrent chemoradiotherapy for FIGO stage IB2-IVA cervical cancer and its clinical prognostic factorsJ Radiat Res201556230531425428244
   PubMed Web of Science ®Google Scholar
• VacchelliEArandaFEggermontATrial watch: tumor-targeting monoclonal antibodies in cancer therapyOncoimmunology201431e2704824605265
   PubMed Web of Science ®Google Scholar
• BabuKGPrabhashKVaidAKNimotuzumab plus chemotherapy versus chemotherapy alone in advanced non-small-cell lung cancer: a multicenter, randomized, open-label phase II studyOnco Targets2014710511060
   PubMed Web of Science ®Google Scholar
• ReddyBKMLokeshVVidyasagarMSNimotuzumab provides survival benefit to patients with inoperable advanced squamous cell carcinoma of the head and neck: a randomized, open-label, phase IIb, 5-year study in India patientsOral Oncol201450549850524613543
   PubMed Web of Science ®Google Scholar
• GarridoGTikhomirovIARabasaABivalent binding by intermediate affinity of nimotuzumab: a contribution to explain antibody clinical profileCancer Biol Ther201111437338221150278
   PubMed Web of Science ®Google Scholar
• MovvaSRodriguezLArias-PulidoHVerschraegenCNovel chemotherapy approaches for cervical cancerCancer2009115143166318019452541
   PubMed Web of Science ®Google Scholar
• NicholsonRIGeeJMHarperMEEGFR and cancer prognosisEur J Cancer200137Suppl 4S9S1511597399
   PubMed Web of Science ®Google Scholar